Diabetes, Cancer, Hepatitis

Brexit 17-01-2018

UK cancer patients must have access to radiotherapy after Euratom exit, warn MPs

MPs have demanded guarantees that UK cancer patients will not lose access to new radiotherapy treatments because of the UK’s withdrawal from the EU’s treaty on nuclear materials.
Agrifood 12-01-2018

Companies set to miss EU acrylamide targets

Food manufacturers risk falling well short of meeting new EU rules aimed at limiting levels of cancer-causing Acrylamide, according to a series of new tests released on Thursday (11 January).
12-12-2017

Combat digestive diseases with tighter controls on the alcohol and food industry

You are what you eat, the saying goes, but what about what we drink? Dietary regulations across Europe need to be stricter if digestive disease rates are to fall, writes Thierry Ponchon.
Health 07-12-2017

Celgene boss: Chronic diseases will bankrupt Europe if incentives are dropped

Alzheimers, diabetes, cancer and other non-communicable diseases will bankrupt Europe if we don’t keep the incentive frameworks alive and well, Mark Alles told EURACTIV.com in an interview.
10-11-2017

Huge inequality in access to cancer care across EU

Europeans face extreme inequality in access to diagnosis and treatment for lung cancer, a report published this week revealed. Experts have called for a harmonised approach to cancer care and greater efforts to promote preventive policies.
13-10-2017

The key to reducing EU cancer deaths

The European Commission is on track to miss its target of decreasing cancer deaths by 15% by 2020. But a focus on thrombosis, the subject of a global awareness campaign today, could turn things around.
Health 12-10-2017

Patients: ‘Think carefully’ before questioning orphan drugs’ incentives

Organisations of patients with rare diseases have warned EU policymakers to “think carefully” before reviewing the incentives in the orphan drugs regulation, claiming that the pharma industry should not be discouraged from investing in new therapies.
Health 10-10-2017

Pharma boss: Targeting drugs won’t make healthcare systems more sustainable

“Salami-slicing” the cost of medicines, which represent almost one-fifth of health system budgets and are subject to rigorous value assessments, won’t make healthcare systems more sustainable in the future, Nathalie Moll told EURACTIV.com in an interview.
Agrifood 05-10-2017

Bringing sanity back to Europe’s glyphosate debate

For glyphosate, the active ingredient in the world’s most widely used weed killer, 6 November will be a date with destiny, writes Pieter Cleppe.
05-10-2017

EU agency OK’d 39 cancer drugs without evidence they work, study shows

The European Medicines Agency approved 39 new cancer drugs between 2009 and 2013 despite having no evidence that they worked, unnecessarily exposing patients to toxicity, researchers said Thursday (5 October).

MEPs vote down endocrine disruptor criteria, back acrylamide regulation

The European Parliament’s environment committee objected to the Commission’s proposed criteria for endocrine disruptors on Thursday (28 September), and threw out another objection to the executive’s proposal to regulate levels of cancer-causing acrylamide in food.
Agrifood 26-09-2017

Food safety advocates speak out as MEP attacks acrylamide regulation

The European Parliament’s environment committee will vote on Thursday (28 September) on a resolution which seeks to stop a Commission proposal to regulate levels of carcinogenic acrylamide in food, amid continuing pleas from food safety advocates to endorse the original proposal.